Successful treatment of EBV-associated posttransplantation lymphoma after cord blood transplantation using third-party EBV-specific cytotoxic T lymphocytes

Cellular therapy of Epstein-Barr virus (EBV)(+) posttransplantation lymphoproliferative diseases (PTLD) in cord blood transplant (CBT) recipients is limited by lack of donor access and the donor's naive neonatal immune system. We therefore used partially human leukocyte antigen–matched third-pa...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Barker, Juliet N., Doubrovina, Ekaterina, Sauter, Craig, Jaroscak, Jennifer J., Perales, Miguel A., Doubrovin, Mikhail, Prockop, Susan E., Koehne, Guenther, O'Reilly, Richard J.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society of Hematology 2010
Materias:
Transplantation
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3012598/
https://ncbi.nlm.nih.gov/pubmed/20826724
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2010-04-281873
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares